Based on the above Chinese and international research findings, it can be concluded that metformin inhibits the proliferation and diffusion of glioma cells by stimulating the AMPK/mTOR signaling pathway, and this mechanism has been verified in experiments and clinical trials. This evidence concerns the gene MTOR and central nervous system cancer.